Market Research Report: Oncology Informatics, Worldwide

Published On : 09-15-2022

In 2015, the global oncology informed North America led the market. Market growth is fueled by factors such as increasing cancer rates in the region, better diagnostic tools, and higher healthcare costs. There are, however, a few restrictions on the market. These challenges restrain the expansion of the industry.

A new analysis from Grand View Research projects a CAGR of 5.7% for the worldwide cancer informatics market from 2016 through 2030. The rising expense of cancer treatment, the rising cost of cancer care, and the growing emphasis on minimizing medical mistakes and hospital readmissions are all factors fueling this expansion.

Market growth projections and analysis are included in the study. The competition environment and essential product positioning are also revealed. Future expansion in various nations is also analyzed. By way of illustration, between 2020 and 2030, it is expected that North America will expand at a compound annual growth rate (CAGR) of XX%.

This market's expansion is being hampered by several problems, including a lack of available skilled workers and a stringent regulatory framework. However, it is anticipated that the market will expand due to the rising incidence of cancer and the incorporation of NGS technology into other research activities.

There are several regional competitors in the oncology informatics industry. Therefore, firms have experimented with many approaches to expansion. Strategies can include spending money on research and development to ensure low prices. For instance, the partnership between Tempus and Precision Health Informatics aims to improve precision medicine in oncology. These shifts should help drive the expansion of the market and usher in new opportunities for businesses in the sector.

Consumers, geographical locations, and product types all affect the market's breakdown. A review of the market during the anticipated time frame is provided for each section. Rising cancer rates and efforts to reduce medical mistakes and hospital readmissions drive demand for oncology information systems. However, the expansion of the market faces several obstacles. A lack of available medical oncologists, the high price of new infrastructure, and worries over the safety of patient data are only a few of these obstacles.

The cancer informatics industry has been affected in several ways by the recent COVID-19 outbreak. It has slowed several processes and thrown a wrench in the supply chain in many countries. Although supplies were quickly replenished, the epidemic presented new difficulties for cancer patients. For instance, cancer patients lacked access to testing and treatment. Furthermore, breast and colorectal cancer screening rates have declined significantly recently.

Inflation caused by the COVID-19 outbreak has made it harder for hospitals to make ends meet. As a result, vendors have modified the way they interact with them. The effect of this shift in dynamics is increased rivalry within the market. In addition, there has been a recent uptick in the number of small, innovative companies entering the market, quickly becoming a formidable competitive challenge.

From 2020 to 2027, the global oncology informatics market is predicted to expand at a low to moderate rate. The increasing prevalence of cancer patients, rising healthcare expenses, and EHR adoption are all to blame for this expansion. The report thoroughly examines the market's essential subsegments, driving factors, and competitive landscape.

More significant cancer treatment costs, a more extensive patient base, and the rising adoption of oncology-specific electronic health records all contribute to the expansion of the oncology informatics industry (EHRs). The industry's primary constraints are inefficient data integration, high installation costs, and data security worries. However, cutting-edge cancer informatics solutions will likely lessen these challenges' impact.

Radiation and surgical oncology represent distinct submarkets within the Oncology Informatics Market. By 2021, the latter is anticipated to hold the lion's market share. Clinicians will be more efficient and have a better work-life balance as electronic health record systems become more widely used.

Between 2017 and 2023, the worldwide market for oncology informatics is projected to expand at a CAGR of 7.2%. The introduction of cutting-edge tools and diagnostic kits is anticipated to fuel this market's expansion. Furthermore, the competitive landscape may shift as a result of new entrants. New entrants can differentiate themselves from the pack by prioritizing creating and implementing cutting-edge technology, simplifying their operations, and reducing their overall operational expenses. On the other hand, established businesses put more effort into introducing new products and negotiating with competitors to increase their market share. If this happens, they risk missing out on the benefits of a successful product launch or financial gain.

The aging population and the rising number of people diagnosed with cancer are two additional factors likely to fuel this market's expansion. In addition, growth in this market is anticipated to be fueled partly by rising investments in life sciences R&D activities and the widespread implementation of electronic health records.

Forecasting Global Clinical Research Trends for 2022

Published On: 09-02-2022

Analysis of the Global Radiation Oncology Market 2022 

Published On :08-12-2022

The growth of the worldwide radiation oncology market is anticipated to be driven by a number of reasons, including the development of healthcare infrastructure and the increase in healthcare expenditures. The study also provides critical geographical details, such as the presence of significant firms and goods. It also contains information on significant end-users, including Change Healthcare, Experian, and the Mayo Clinic. However, various obstacles, such as the price of the products and services, the complexity of the procedure, and the high price of radiation treatment devices, may limit the market's expansion.

The Global Radiation Oncology Market Analysis Report offers an in-depth data of the industry, including major drivers and inhibitors, product and application trends, as well as regional market analysis. Additionally, the study evaluates the competition landscape, including historical and current statistics, technological breakthroughs, and future market trends. In addition, it describes market drivers, challenges, and opportunities, as well as major market participants in the worldwide radiation oncology industry.

In addition, the research evaluates revenue, sales, and consumption patterns across several geographies. Additionally, the study covers the market's major players, providing their financial statements and business biographies. This enables the sector to comprehend the rivalry in diverse places and make the most growth-promoting selections. Keep in mind, when analyzing the worldwide radiation oncology market, that it will stay competitive through 2027, which may restrict expansion in the coming years.

By 2021, the radiation oncology market in North America is anticipated to reach $1.2 billion. This expansion is attributable to increased healthcare costs and novel anticancer procedures. In addition, the presence of major market participants in North America is anticipated to help to market expansion. This region is anticipated to have the most expansion in the future years. In addition, the paper examines the expansion of radiation oncology in Asia-Pacific.

The rising prevalence of cancer in Asia is likely to boost the market expansion of radiation oncology. Asia has a lower incidence of cancer than other areas, but the number of cases is predicted to rise. This will ultimately result in a more rapid expansion of the radiation oncology sector. By 2022, the area will have a CAGR of approximately 6%. The research also identifies important growth factors for the radiation oncology industry.

Additionally, the research examines the competitive landscape of the radiotherapy industry. Becton, Dickinson and Company, Elekta AB, IBA (Ion Beam Applications SA), Eckert & Ziegler Group, Mevion Medical Systems Inc., and Siemens Healthineers are key market participants. In addition, the study shows the strength of suppliers and purchasers. In addition, the study describes the regulatory and legal structure that oversees radiotherapy.

In 2022, radiation oncology goods and services are anticipated to account for over half of the market in North America. It is anticipated that the region's healthcare infrastructure and experienced healthcare workers will contribute to this expansion. In addition, the existence of notable market participants, such as Accuray Incorporated, Nordion Inc., and Varian Medical Systems, is anticipated to stimulate the expansion of the industry. Additionally, an increasing number of cancer patients is anticipated to fuel the market.

External Beam Radiation Therapy: The external beam sector is anticipated to account for a significant part of the market in 2020, and to produce revenues of $11,638,2 million by 2030. It involves the deposition of high-energy radiation on the tumor, which successfully eliminates cancer cells without harming normal tissues. Depending on the patient's treatment, photons, electrons, and protons are utilized in external beam radiation therapy. In addition, it is more precise in killing aberrant cells, reducing discomfort.

Radiation oncology technologies will continue to progress in the foreseeable future. Introducing innovative radiation equipment and procedures will enhance treatment efficacy and security. Technological advances will drive the market even further. For instance, 4D radiotherapy enables physicians to follow the tumor in real time, account for organ movement, and apply conformal radiation. In addition, sophisticated therapy approaches can aid people with disorders so complex that standard therapies are ineffective.

Top 10 Most Read Radiology Technology Content in March 2022

Published On : 08-02-2022

Radiology technologists' career prospects are a hot topic in today's job market. We've compiled the top ten articles on the subject to give you a clear picture of what to expect. Here are a few things to consider, ranging from educational requirements to job prospects. Top 10 Most Read Radiology Technology Content in March 2022

Radiology technicians have a promising future.

The demand for radiologic technologists is expected to increase further, resulting in a 21 percent increase in overall job growth between 2012 and 2022. This is because the number of people affected by various medical conditions is expected to rise during this period, particularly osteoporosis, which causes breaks and requires imaging to diagnose. According to a 2005 survey of radiologic technologists, one of the top reasons to work in this field was the ability to work a flexible schedule. Radiologic technologists work forty hours per week on average, including some evening and weekend shifts.

This profession's salary is expected to rise by 19% by 2022, slightly faster than the national average. While there are many job openings in this field, many are not directly related to a specific medical specialty. For example, some radiology technicians work in hospitals, while others complete some of their education at accredited two-year colleges. Therefore, brilliant work and dedication are required to obtain this position.

A high school diploma or GED, as well as an associate's degree in a relevant field, are required for a job in radiology. Most people pursue an Associate of Applied Science (AAS) degree in radiology technology. This degree will teach you about medical imaging technology and human anatomy. You will also have the opportunity to work with cadavers. After completing your education, you should be able to find work as a radiology technologist in March 2022.

Education requirements for radiology technologists

The education requirements for radiology technologists in March 2020 will remain a significant factor in the field's growth. The area necessitates a delicate balance of technical skills and a desire to help people. The radiologic technology profession is rapidly expanding, and the job is dynamic, with new daily challenges. Here are some pointers to help you get started in the field:

An associate's degree in radiologic technology can help you get an entry-level job and professional development and career advancement. According to Emsi Burning Glass data, one-fourth of radiologic technologists have a bachelor's degree. In addition, the education requirements for radiology technologists in March 2022 will be the same as they are now. This is because bachelor's degrees can provide working professionals with specialized skills that are essential in the field of medical imaging.

The Joint Review Committee on Education for Radiologic Technologists will certify the program (JRCERT). Graduates are eligible for state licensure and the American Registry of Radiologic Technologists examination. To be considered for admission, students must submit a background check and a health report. In addition, they must have at least a 2.0 GPA in the required radiologic technology courses. Finally, all core courses must be taken in the same order. Graduation requires 77 credit hours in total.

Job prospects for radiology technologists

As the average American worker ages, the job outlook for radiology technologists is generally favorable. However, while the overall job outlook is positive, the field is still undergoing changes that may alter the nature of the job. A recent pandemic, for example, has prompted many radiologists to look for work-from-home opportunities that allow them to work when and where they want. Furthermore, radiology is self-explanatory, making remote work arrangements possible.

A bachelor's degree in radiology technology or equivalent education is required. However, many job postings do not specify experience requirements. Furthermore, 62% of radiology technologist job advertisements do not determine whether applicants have previous work experience. Earning a certificate from the American Registry of Radiologic Technologists (ARRT) is considered equivalent to other professional credentials. As a result, making a certificate from this organization will put you on par with the vast majority of radiology technologists worldwide.

Radiographers are in high demand, with the number of new positions outnumbering the available ranks. According to the American College of Radiology, the number of unique jobs posted will continue to rise throughout the year. Radiologists are expected to be in high demand for the foreseeable future. According to the Bureau of Labor Statistics, there are currently around 50,000 radiology job openings, which is expected to rise further.

Proton Therapy Is Now a Common Cancer Treatment Option

Published On: 05/25/2022

According to Michael Dattoli, clinical trials have looked into several of the advantages of proton therapy for cancer. These benefits include fewer problems, targeting cancer cells with double-stranded DNA, and shielding important organs. The following are some of the most important advantages of proton treatment. Continue reading to find out more. You'll also learn about its advantages over regular radiation therapy. So, how is proton treatment superior than traditional radiation therapy?

Protons have been contentious in cancer treatment, but new study supports their usage. The risks of cancer and other consequences were compared to those of photon-based treatment by researchers from the National Cancer Institute and the University of Pennsylvania. The study's findings, however, are inconclusive and require additional investigation. While the overall advantages of proton treatment remain hopeful, the study's implications are limited by a number of critical factors.

Michael Dattoli believes that, patients with a liver tumor should be informed of the dangers of radiation. Proton treatment is less toxic and has a lower risk of problems than standard radiation therapy. It is also very successful in destroying malignancies that are adjacent to vital tissues and organs, such as the spinal cord and bone marrow. Furthermore, this type of cancer treatment delivers a greater, curative dosage of radiation to the tumor while lowering the chance of adverse effects.

Proton therapy is a type of radiation therapy that employs charged protons to attack tumors and destroy malignant DNA. The therapy is beneficial since it may be used in conjunction with chemotherapy and surgery, as well as on its own. Proton therapy's adaptability provides cancer patients a fighting chance in their fight against the illness. Proton therapy research was pioneered at MD Anderson Cancer Center in Houston, Texas.

While proton-based therapy may target every type of cancer cell, there are several choices available. The Comprehensive Cancer Panel from Ion Torrent, for example, addresses all exons of critical tumor suppressor genes, as well as oncogenes and their CDS variations. The Comprehensive Cancer Panel also examines the mutational spectrum of numerous gene families, as well as apoptosis and signaling cascade pathways.

Nontarget structures get less dose with IMRT and photon treatments. Proton significantly decreases the radiation on supratentorial of 20 Gy. PT and photon treatment are both possible and safe in individuals with pediatric ependymoma. Proton treatment considerably lowers the dosage of OARs. Dose escalation should be avoided in infratentorial tumors with substantial volumes, extensive encasements of the brainstem, and cervical medullary involvement. Dose escalation, on the other hand, might be employed in patients with supratentorial tumors who are at high risk of relapse.

The study's findings revealed that protons were more efficient than photons at reducing exposure to OARs. Photons were known to produce transverse pictures and excess dosage. The dosage to the temporal lobes and brainstem was lowered by protons. These findings suggest that proton therapy outperforms photon treatment. However, there is still plenty to learn. Wankel et alinvestigation .'s confirmed that proton lowers dosage on supratentorial of 20 Gy.

Proton therapy was employed on patients with cancer of the oropharynx (the portion of the throat behind the mouth) in a research at MD Anderson Cancer Center. Proton therapy is a cutting-edge cancer treatment that protects essential organs while enhancing patients' quality of life. Proton treatment is extremely successful in treating complicated head and neck malignancies. Multidisciplinary teams are required for proton treatment.

In Michael Dattoli's opinion, because pediatric patients are more vulnerable to the long-term consequences of cancer treatment, proton therapy is more successful in treating them. Furthermore, two-thirds of children with cancer acquire at least one chronic health issue, and one-fourth of childhood cancer survivors endure serious side effects in adulthood, including heart damage, lung damage, infertility, cognitive impairments, growth deficits, and hearing loss. Proton therapy can also be used to treat cancer, especially secondary tumors. 

Recent Radiotherapy Advances in 2022

Published on: 05-18-2022

According to Michael Dattoli, advanced imaging and hypofractionation are critical components of radiation therapy delivery. These advanced techniques include intensity-modulated radiotherapy, image-guided therapy, proton beam therapy, and stereotactic body radiotherapy. These techniques allow for a higher dose to be delivered to the target while sparing healthy tissue. They can, however, be complicated by uncertainties in imaging, treatment planning, and tumor size.

Hypofractionated radiotherapy reduces the number of radiation treatments required. Because the patient receives less radiation, this type of treatment may improve the patient's quality of life. Furthermore, patients may need fewer sessions, resulting in fewer visits to the cancer center and fewer unpleasant side effects. Furthermore, advanced imaging and hypofractionation reduce the amount of radiation exposure to healthy tissues, making treatment easier.

Michael Dattoli thinks that the BELLA team is working to develop a new targeting technology that will focus lasers to higher intensities and generate higher-energy protons. The current focusing system produces only powerful enough beams to deliver FLASH radiotherapy to thin sheets. Ion beams with higher energies will penetrate deeper into living tissue. According to co-author Jian-Hua Mao, the new technology could eventually be used in radiotherapy.

Despite the limitations of traditional radiotherapy, technological advances have increased its efficacy. Hypofractionated radiotherapy allows doctors to deliver higher doses in less time. In addition to hypofractionation, doctors can use stereotactic body radiotherapy to perform one to five treatments. This technique has also paved the way for more effective, safer treatments. Because of the numerous advantages it provides, this method is gaining popularity.

According to recent research, the use of advanced radiation techniques for patients with head and neck cancer has increased over time. According to the National Cancer Database, more patients are receiving advanced radiation therapy for this disease. Advanced radiation therapy has been used in 78 percent of relevant cases since 2004. Disparities do exist, however, across racial, socioeconomic, and geographic groups. Patients from minority and low-income backgrounds, the researchers discovered, are less likely to receive advanced radiation techniques.

Michael Dattoli feels that the use of imaging biomarkers allows clinicians to target areas at higher risk of radio-resistance and allow for biologically focused dose escalation. Advanced imaging during radiation therapy, including artificial intelligence, is critical to improving radiotherapy and reducing long-term toxicities. This technology will be used in the future of radiation therapy. It should be noted that advanced imaging is only one of many tools available in the field.

RADIATION ONCOLOGY IN THE FUTURE: ARTIFICIAL INTELLIGENCE AND THE FUTURE

Published On: 04-28-2022

According to Michael Dattoli, artificial intelligence (AI) has been implemented in 37% of radiotherapy clinics and is expected to grow rapidly over the next five years. Additionally, numerous medical physicists have indicated a need for commissioning and quality assurance guidelines. In this article, we'll discuss some of the major benefits and challenges associated with artificial intelligence in radiation oncology. Additionally, we consider the impact of AI on the patient experience and discuss some of the ethical concerns.

Concerns about GDPR are one roadblock to AI adoption. Despite the fact that many centers have signed data-sharing agreements with data-sharing companies, physicians continue to harbor widespread doubts about the efficacy of delegating these decisions to machines. Additionally, despite AI's obvious potential, many physicians have reservations about its use in healthcare. However, there is mounting evidence that artificial intelligence is advancing the field of radiation oncology.

AI has the potential to significantly enhance the qualitative interpretation of cancer imaging, including the volumetric delineation of tumors over time. Additionally, it can aid in extrapolating the tumor's biological course based on its genotype. Ultimately, it has the potential to improve treatment planning and patient satisfaction. However, how does AI contribute to the improvement of the radiotherapy process? By incorporating artificial intelligence into radiotherapy, we can improve the accuracy and personalization of our radiation therapy. In the coming years, we'll learn more about AI and the field of radiation oncology.

Michael Dattoli described that, meanwhile, AI will assist physicians in improving the quality of treatment, reducing the burden of side effects, and increasing survival. Additionally, it will assist radiation oncologists in establishing themselves as responsible medical doctors who are involved throughout the patient's care path. This requires radiation oncologists to become more actively involved in multidisciplinary patient care. Artificial intelligence will assist radiation oncologists in redefining their roles and enhancing patient outcomes. You could be one of the first physicians to benefit from artificial intelligence in radiation oncology.

Despite the numerous benefits of AI, many people are uncertain about its impact on radiotherapy. While AI-based tools have the potential to significantly improve the efficiency and quality of radiation therapy, numerous barriers must be overcome before AI can be fully integrated into clinical practice. We'll discuss AI in radiation oncology in the following post, where we'll examine the potential applications of AI in radiotherapy and how it might impact the field's future.

Numerous recent studies have demonstrated artificial intelligence's potential benefits in medicine. The use of deep learning (DL) algorithms in diagnostic imaging is one example. These techniques develop predictive models by combining artificial intelligence and low-level sensory data. AI algorithms can be used to improve cancer screening, COVID-19 chest CT scans, and other procedures. In the long run, artificial intelligence will significantly improve the accuracy and quality of radiation oncology care.

IBM's Watson for Oncology is another example of how AI is being used in cancer treatment. The AI-based cancer management system is demonstrated to be highly congruent with tumor board recommendations. It has, however, been slow to demonstrate efficacy in other areas of oncology decision-making. Despite these obstacles, Watson has the potential to significantly improve clinical practice. This technology has the potential to fundamentally alter the way radiation oncologists plan their treatments.

Artificial intelligence has the potential to significantly improve the quality of patient care and reduce planning time in radiotherapy. This advancement has been facilitated by recent advancements in computing algorithms and cloud-based computing. By optimizing the workflow of radiation oncologists and their staff, machine learning algorithms can improve patient care. However, there are numerous limitations to using AI in radiation oncology. Among other factors, AI has the potential to be a disruptive technology in radiology.

Michael Dattoli revealed that, aI is already able to improve radiology workflow and diagnose patients more accurately thanks to machine learning. Additionally, these artificial intelligence methods can improve the quality of radiation oncology by reducing unnecessary imaging and characterization of findings. For instance, an intelligent MR imager may suggest sequence modifications during a scan. Intelligent MR imagers may help radiologists save money, time, and effort. Machine learning has far-reaching implications in radiation oncology.

Machine learning is a technique that utilizes mathematical and statistical techniques to automatically construct predictive models. Without explicit programming, these systems can predict outcomes using training data. Artificial Intelligence (AI) makes use of Artificial Neural Networks (ANNs), which are modeled after biological neural networks. ANNs are composed of layers, each of which contains a set of neurons. Each neuron is fully connected to all neurons in the preceding layer, and each neuron has a weighted value that indicates its strength. The more data they collect, the more precise the results will be.